SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2352Cliffs Notes version of the Court’s ruling on SNY’s request: siliconinvestor.coDewDiligence_on_SI-7/27/2010
2351Craig Wheeler told investors and analysts to expect this on last week's CC.DewDiligence_on_SI-7/26/2010
2350reuters.com Sanofi has fired the first shot via the courts.......will be intereArthur Radley-7/26/2010
2349My guess is that there's a small number of buyers where lowest price is the Ian@SI-7/26/2010
2348I didn't think they made any sense either way. It always surprises me how rkrw-7/26/2010
2347No, IMO. The analyst's forecasts posted by rkrw do not make sense if the genDewDiligence_on_SI-7/26/2010
2346So as long as MNTA has the only approved generic, is it reasonable to assume thaIan@SI-7/26/2010
2345NVS priced generic Lovenox at a 14% discount to the branded product, according tDewDiligence_on_SI-7/26/2010
2344MNTA ‘ReadMeFirst’ updated: <i>Major rewrite for FDA approval of genericDewDiligence_on_SI-7/26/2010
2343Usually the response is to RAISE your price! Automatic substitution will hit arkrw-7/26/2010
2342Dumb question - in the face of that sort of competition, why not just lower the tom pope-7/26/2010
2341Jefferies Lovenox estimate from their Pharma analyst 2010: from 2725 to 2341 2rkrw-7/26/2010
2340A summary dismissal would eliminate the H-W 30-month stay if upheld by the appelDewDiligence_on_SI-7/25/2010
2339Hypothetically if Teva's suit is dismissed wouldn't that remove the 30 mrkrw-7/25/2010
2338MNTA 2010-2011 Possible/Probable News Flow: siliconinvestor.comDewDiligence_on_SI-7/25/2010
2337Hard to think of reasons Novartis wouldn't want to buy them.D.Lu-7/25/2010
2336NVS’ own PR on generic Lovenox settles the ACS “carve-out” issue: siliconinvestDewDiligence_on_SI-7/25/2010
2335>>Looking ahead for Momenta, its first FDA approval is an endorsement of tnigel bates-7/25/2010
2334FDA Approves Generic Lovenox By ALICIA MUNDY WASHINGTON—The Food and Drug Adrkrw-7/24/2010
2333To say the least, it is convenient.rkrw-7/24/2010
2332Talk about two-faced: prescriptions.blogs.nytimes.com "...The manufactureJeffry K. Smith17/24/2010
2331Up 70%! It Was Worth the Wait By Brian Orelli, Ph.D. | July 23, 2010 | It mlkr-7/24/2010
2330I've been told there was a "generic" in Brazil that was pulled frorkrw-7/23/2010
2329Whatever Teva has done to date has now been shown to not be enough, so they haverkrw-7/23/2010
2328The last post on IHub (99550) at this moment raises a good question: siliconinvJeffry K. Smith-7/23/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News